CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy, such as CCI-779, work in different ways to stop tumor cells from
dividing so they stop growing or die. This phase II trial is studying how well CCI-779 works
in treating patients with locally advanced or metastatic pancreatic cancer